AnaCardio appoints Elin Rosendahl as CDO
Stockholm, Sweden, April 3, 2024 AnaCardio AB announces today the appointment of Elin Rosendahl, MSc as Chief Development Officer (CDO). Elin has more than 20 years of experience in managing global biopharmaceutical development programs and leading global cross-functional teams in both small and large pharma companies, and joins AnaCardio from her previous role as Vice […]